Artificial intelligence (AI) has been the market’s favorite catalyst over the past year, fueling rallies across everything from chipmakers to cloud software stocks. But one of the more surprising success stories has come from healthcare, a sector not usually known for flashy AI-driven growth. That’s where Tempus AI (TEM) enters the picture. Going public just last year, Tempus is already experiencing sharp revenue gains and notable improvements in the bottom line, unlike the typical biotech IPOs that often ...